Építés alatt – nem éles oldal
Belépés

Alzheimer-kór trials, also abroad

822 open Alzheimer-kór trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Egyesült Államok361
Kína134
Franciaország85
Olaszország60
Kanada58
All other countries

The same trial often runs in several countries

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) has 3 sites in Chile and runs in 31 countries. If a site near you is full, another one may still take people.

See Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) in all 31 countries